Global Bio Similars & Subsequent Entry Biologic Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Bio Similars & Subsequent Entry Biologic Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bio Similars & Subsequent Entry Biologic Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Monoclonal Antibodies
1.2.3 Interferon
1.2.4 Erythropoietin
1.2.5 Insulin
1.2.6 Vaccines
1.2.7 Other
1.3 Market by Application
1.3.1 Global Bio Similars & Subsequent Entry Biologic Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Bio Similars & Subsequent Entry Biologic Market Size (2017-2028)
2.2 Bio Similars & Subsequent Entry Biologic Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Bio Similars & Subsequent Entry Biologic Market Size by Region (2017-2022)
2.4 Global Bio Similars & Subsequent Entry Biologic Market Size Forecast by Region (2023-2028)
2.5 Global Top Bio Similars & Subsequent Entry Biologic Countries Ranking by Market Size
3 Bio Similars & Subsequent Entry Biologic Competitive by Company
3.1 Global Bio Similars & Subsequent Entry Biologic Revenue by Players
3.1.1 Global Bio Similars & Subsequent Entry Biologic Revenue by Players (2017-2022)
3.1.2 Global Bio Similars & Subsequent Entry Biologic Market Share by Players (2017-2022)
3.2 Global Bio Similars & Subsequent Entry Biologic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Bio Similars & Subsequent Entry Biologic Revenue
3.4 Global Bio Similars & Subsequent Entry Biologic Market Concentration Ratio
3.4.1 Global Bio Similars & Subsequent Entry Biologic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bio Similars & Subsequent Entry Biologic Revenue in 2021
3.5 Global Bio Similars & Subsequent Entry Biologic Key Players Head office and Area Served
3.6 Key Players Bio Similars & Subsequent Entry Biologic Product Solution and Service
3.7 Date of Enter into Bio Similars & Subsequent Entry Biologic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Bio Similars & Subsequent Entry Biologic Breakdown Data by Type
4.1 Global Bio Similars & Subsequent Entry Biologic Historic Revenue by Type (2017-2022)
4.2 Global Bio Similars & Subsequent Entry Biologic Forecasted Revenue by Type (2023-2028)
5 Global Bio Similars & Subsequent Entry Biologic Breakdown Data by Application
5.1 Global Bio Similars & Subsequent Entry Biologic Historic Market Size by Application (2017-2022)
5.2 Global Bio Similars & Subsequent Entry Biologic Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Bio Similars & Subsequent Entry Biologic Revenue by Company (2020-2022)
6.2 North America Bio Similars & Subsequent Entry Biologic Revenue by Type (2017-2028)
6.3 North America Bio Similars & Subsequent Entry Biologic Revenue by Application (2017-2028)
6.4 North America Bio Similars & Subsequent Entry Biologic Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Bio Similars & Subsequent Entry Biologic Revenue by Company (2020-2022)
7.2 Europe Bio Similars & Subsequent Entry Biologic Revenue by Type (2017-2028)
7.3 Europe Bio Similars & Subsequent Entry Biologic Revenue by Application (2017-2028)
7.4 Europe Bio Similars & Subsequent Entry Biologic Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Bio Similars & Subsequent Entry Biologic Revenue by Company (2020-2022)
8.2 Asia Pacific Bio Similars & Subsequent Entry Biologic Revenue by Type (2017-2028)
8.3 Asia Pacific Bio Similars & Subsequent Entry Biologic Revenue by Application (2017-2028)
8.4 Asia Pacific Bio Similars & Subsequent Entry Biologic Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Bio Similars & Subsequent Entry Biologic Revenue by Company (2020-2022)
9.2 Latin America Bio Similars & Subsequent Entry Biologic Revenue by Type (2017-2028)
9.3 Latin America Bio Similars & Subsequent Entry Biologic Revenue by Application (2017-2028)
9.4 Latin America Bio Similars & Subsequent Entry Biologic Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Bio Similars & Subsequent Entry Biologic Revenue by Company (2020-2022)
10.2 Middle East and Africa Bio Similars & Subsequent Entry Biologic Revenue by Type (2017-2028)
10.3 Middle East and Africa Bio Similars & Subsequent Entry Biologic Revenue by Application (2017-2028)
10.4 Middle East and Africa Bio Similars & Subsequent Entry Biologic Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Sun Pharma
11.1.1 Sun Pharma Company Details
11.1.2 Sun Pharma Business Overview
11.1.3 Sun Pharma Bio Similars & Subsequent Entry Biologic Products and Services
11.1.4 Sun Pharma Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.1.5 Sun Pharma Bio Similars & Subsequent Entry Biologic SWOT Analysis
11.1.6 Sun Pharma Recent Developments
11.2 Synthon Pharmaceuticals
11.2.1 Synthon Pharmaceuticals Company Details
11.2.2 Synthon Pharmaceuticals Business Overview
11.2.3 Synthon Pharmaceuticals Bio Similars & Subsequent Entry Biologic Products and Services
11.2.4 Synthon Pharmaceuticals Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.2.5 Synthon Pharmaceuticals Bio Similars & Subsequent Entry Biologic SWOT Analysis
11.2.6 Synthon Pharmaceuticals Recent Developments
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Company Details
11.3.2 Teva Pharmaceutical Industries Business Overview
11.3.3 Teva Pharmaceutical Industries Bio Similars & Subsequent Entry Biologic Products and Services
11.3.4 Teva Pharmaceutical Industries Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.3.5 Teva Pharmaceutical Industries Bio Similars & Subsequent Entry Biologic SWOT Analysis
11.3.6 Teva Pharmaceutical Industries Recent Developments
11.4 LG Life Sciences
11.4.1 LG Life Sciences Company Details
11.4.2 LG Life Sciences Business Overview
11.4.3 LG Life Sciences Bio Similars & Subsequent Entry Biologic Products and Services
11.4.4 LG Life Sciences Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.4.5 LG Life Sciences Bio Similars & Subsequent Entry Biologic SWOT Analysis
11.4.6 LG Life Sciences Recent Developments
11.5 Celltrion Biocon
11.5.1 Celltrion Biocon Company Details
11.5.2 Celltrion Biocon Business Overview
11.5.3 Celltrion Biocon Bio Similars & Subsequent Entry Biologic Products and Services
11.5.4 Celltrion Biocon Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.5.5 Celltrion Biocon Bio Similars & Subsequent Entry Biologic SWOT Analysis
11.5.6 Celltrion Biocon Recent Developments
11.6 Hospira
11.6.1 Hospira Company Details
11.6.2 Hospira Business Overview
11.6.3 Hospira Bio Similars & Subsequent Entry Biologic Products and Services
11.6.4 Hospira Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.6.5 Hospira Bio Similars & Subsequent Entry Biologic SWOT Analysis
11.6.6 Hospira Recent Developments
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Bio Similars & Subsequent Entry Biologic Products and Services
11.7.4 Merck Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.7.5 Merck Bio Similars & Subsequent Entry Biologic SWOT Analysis
11.7.6 Merck Recent Developments
11.8 Biogen idec
11.8.1 Biogen idec Company Details
11.8.2 Biogen idec Business Overview
11.8.3 Biogen idec Bio Similars & Subsequent Entry Biologic Products and Services
11.8.4 Biogen idec Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.8.5 Biogen idec Bio Similars & Subsequent Entry Biologic SWOT Analysis
11.8.6 Biogen idec Recent Developments
11.9 Genentech (Roche)
11.9.1 Genentech (Roche) Company Details
11.9.2 Genentech (Roche) Business Overview
11.9.3 Genentech (Roche) Bio Similars & Subsequent Entry Biologic Products and Services
11.9.4 Genentech (Roche) Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.9.5 Genentech (Roche) Bio Similars & Subsequent Entry Biologic SWOT Analysis
11.9.6 Genentech (Roche) Recent Developments
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Bio Similars & Subsequent Entry Biologic Products and Services
11.10.4 Pfizer Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.10.5 Pfizer Bio Similars & Subsequent Entry Biologic SWOT Analysis
11.10.6 Pfizer Recent Developments
11.11 Celltrion
11.11.1 Celltrion Company Details
11.11.2 Celltrion Business Overview
11.11.3 Celltrion Bio Similars & Subsequent Entry Biologic Products and Services
11.11.4 Celltrion Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.11.5 Celltrion Recent Developments
11.12 Biocon
11.12.1 Biocon Company Details
11.12.2 Biocon Business Overview
11.12.3 Biocon Bio Similars & Subsequent Entry Biologic Products and Services
11.12.4 Biocon Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.12.5 Biocon Recent Developments
11.13 Amgen
11.13.1 Amgen Company Details
11.13.2 Amgen Business Overview
11.13.3 Amgen Bio Similars & Subsequent Entry Biologic Products and Services
11.13.4 Amgen Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.13.5 Amgen Recent Developments
11.14 Samsung Biologics
11.14.1 Samsung Biologics Company Details
11.14.2 Samsung Biologics Business Overview
11.14.3 Samsung Biologics Bio Similars & Subsequent Entry Biologic Products and Services
11.14.4 Samsung Biologics Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.14.5 Samsung Biologics Recent Developments
11.15 Mylan
11.15.1 Mylan Company Details
11.15.2 Mylan Business Overview
11.15.3 Mylan Bio Similars & Subsequent Entry Biologic Products and Services
11.15.4 Mylan Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.15.5 Mylan Recent Developments
11.16 Dr. Reddy's Laboratories
11.16.1 Dr. Reddy's Laboratories Company Details
11.16.2 Dr. Reddy's Laboratories Business Overview
11.16.3 Dr. Reddy's Laboratories Bio Similars & Subsequent Entry Biologic Products and Services
11.16.4 Dr. Reddy's Laboratories Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.16.5 Dr. Reddy's Laboratories Recent Developments
11.17 Stada Arzneimittel AG
11.17.1 Stada Arzneimittel AG Company Details
11.17.2 Stada Arzneimittel AG Business Overview
11.17.3 Stada Arzneimittel AG Bio Similars & Subsequent Entry Biologic Products and Services
11.17.4 Stada Arzneimittel AG Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.17.5 Stada Arzneimittel AG Recent Developments
11.18 AbbVie
11.18.1 AbbVie Company Details
11.18.2 AbbVie Business Overview
11.18.3 AbbVie Bio Similars & Subsequent Entry Biologic Products and Services
11.18.4 AbbVie Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.18.5 AbbVie Recent Developments
11.19 Sanofi-Aventis
11.19.1 Sanofi-Aventis Company Details
11.19.2 Sanofi-Aventis Business Overview
11.19.3 Sanofi-Aventis Bio Similars & Subsequent Entry Biologic Products and Services
11.19.4 Sanofi-Aventis Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.19.5 Sanofi-Aventis Recent Developments
11.20 Johnson & Johnson
11.20.1 Johnson & Johnson Company Details
11.20.2 Johnson & Johnson Business Overview
11.20.3 Johnson & Johnson Bio Similars & Subsequent Entry Biologic Products and Services
11.20.4 Johnson & Johnson Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.20.5 Johnson & Johnson Recent Developments
11.21 Novo Nordisk
11.21.1 Novo Nordisk Company Details
11.21.2 Novo Nordisk Business Overview
11.21.3 Novo Nordisk Bio Similars & Subsequent Entry Biologic Products and Services
11.21.4 Novo Nordisk Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.21.5 Novo Nordisk Recent Developments
11.22 Eli Lilly
11.22.1 Eli Lilly Company Details
11.22.2 Eli Lilly Business Overview
11.22.3 Eli Lilly Bio Similars & Subsequent Entry Biologic Products and Services
11.22.4 Eli Lilly Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.22.5 Eli Lilly Recent Developments
11.23 Novartis
11.23.1 Novartis Company Details
11.23.2 Novartis Business Overview
11.23.3 Novartis Bio Similars & Subsequent Entry Biologic Products and Services
11.23.4 Novartis Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.23.5 Novartis Recent Developments
11.24 3sbio
11.24.1 3sbio Company Details
11.24.2 3sbio Business Overview
11.24.3 3sbio Bio Similars & Subsequent Entry Biologic Products and Services
11.24.4 3sbio Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.24.5 3sbio Recent Developments
11.25 Biotech
11.25.1 Biotech Company Details
11.25.2 Biotech Business Overview
11.25.3 Biotech Bio Similars & Subsequent Entry Biologic Products and Services
11.25.4 Biotech Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.25.5 Biotech Recent Developments
11.26 Gelgen
11.26.1 Gelgen Company Details
11.26.2 Gelgen Business Overview
11.26.3 Gelgen Bio Similars & Subsequent Entry Biologic Products and Services
11.26.4 Gelgen Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.26.5 Gelgen Recent Developments
11.27 Innovent
11.27.1 Innovent Company Details
11.27.2 Innovent Business Overview
11.27.3 Innovent Bio Similars & Subsequent Entry Biologic Products and Services
11.27.4 Innovent Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.27.5 Innovent Recent Developments
11.28 Dong Bao
11.28.1 Dong Bao Company Details
11.28.2 Dong Bao Business Overview
11.28.3 Dong Bao Bio Similars & Subsequent Entry Biologic Products and Services
11.28.4 Dong Bao Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.28.5 Dong Bao Recent Developments
11.29 Ganlee
11.29.1 Ganlee Company Details
11.29.2 Ganlee Business Overview
11.29.3 Ganlee Bio Similars & Subsequent Entry Biologic Products and Services
11.29.4 Ganlee Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022)
11.29.5 Ganlee Recent Developments
12 Bio Similars & Subsequent Entry Biologic Market Dynamics
12.1 Bio Similars & Subsequent Entry Biologic Market Trends
12.2 Bio Similars & Subsequent Entry Biologic Market Drivers
12.3 Bio Similars & Subsequent Entry Biologic Market Challenges
12.4 Bio Similars & Subsequent Entry Biologic Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Bio Similars & Subsequent Entry Biologic Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Interferon
Table 4. Key Players of Erythropoietin
Table 5. Key Players of Insulin
Table 6. Key Players of Vaccines
Table 7. Key Players of Other
Table 8. Global Bio Similars & Subsequent Entry Biologic Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 9. Global Bio Similars & Subsequent Entry Biologic Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 10. Global Bio Similars & Subsequent Entry Biologic Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Bio Similars & Subsequent Entry Biologic Revenue Market Share by Region (2017-2022)
Table 12. Global Bio Similars & Subsequent Entry Biologic Revenue by Players (2017-2022) & (US$ Million)
Table 13. Global Bio Similars & Subsequent Entry Biologic Market Share by Players (2017-2022)
Table 14. Global Top Bio Similars & Subsequent Entry Biologic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio Similars & Subsequent Entry Biologic as of 2021)
Table 15. Ranking of Global Top Bio Similars & Subsequent Entry Biologic Companies by Revenue (US$ Million) in 2021
Table 16. Global 5 Largest Players Market Share by Bio Similars & Subsequent Entry Biologic Revenue (CR5 and HHI) & (2017-2022)
Table 17. Key Players Headquarters and Area Served
Table 18. Key Players Bio Similars & Subsequent Entry Biologic Product Solution and Service
Table 19. Date of Key Manufacturers Enter into Bio Similars & Subsequent Entry Biologic Market
Table 20. Mergers & Acquisitions, Expansion Plans
Table 21. Global Bio Similars & Subsequent Entry Biologic Market Size by Type (2017-2022) & (US$ Million)
Table 22. Global Bio Similars & Subsequent Entry Biologic Revenue Market Share by Type (2017-2022)
Table 23. Global Bio Similars & Subsequent Entry Biologic Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 24. Global Bio Similars & Subsequent Entry Biologic Revenue Market Share by Type (2023-2028)
Table 25. Global Bio Similars & Subsequent Entry Biologic Market Size by Application (2017-2022) & (US$ Million)
Table 26. Global Bio Similars & Subsequent Entry Biologic Revenue Market Share by Application (2017-2022)
Table 27. Global Bio Similars & Subsequent Entry Biologic Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 28. Global Bio Similars & Subsequent Entry Biologic Revenue Market Share by Application (2023-2028)
Table 29. North America Bio Similars & Subsequent Entry Biologic Revenue by Company (2020-2022) & (US$ Million)
Table 30. North America Bio Similars & Subsequent Entry Biologic Revenue by Type (2017-2022) & (US$ Million)
Table 31. North America Bio Similars & Subsequent Entry Biologic Revenue by Type (2023-2028) & (US$ Million)
Table 32. North America Bio Similars & Subsequent Entry Biologic Revenue by Application (2017-2022) & (US$ Million)
Table 33. North America Bio Similars & Subsequent Entry Biologic Revenue by Application (2023-2028) & (US$ Million)
Table 34. North America Bio Similars & Subsequent Entry Biologic Revenue by Country (2017-2022) & (US$ Million)
Table 35. North America Bio Similars & Subsequent Entry Biologic Revenue by Country (2023-2028) & (US$ Million)
Table 36. Europe Bio Similars & Subsequent Entry Biologic Revenue by Company (2020-2022) & (US$ Million)
Table 37. Europe Bio Similars & Subsequent Entry Biologic Revenue by Type (2017-2022) & (US$ Million)
Table 38. Europe Bio Similars & Subsequent Entry Biologic Revenue by Type (2023-2028) & (US$ Million)
Table 39. Europe Bio Similars & Subsequent Entry Biologic Revenue by Application (2017-2022) & (US$ Million)
Table 40. Europe Bio Similars & Subsequent Entry Biologic Revenue by Application (2023-2028) & (US$ Million)
Table 41. Europe Bio Similars & Subsequent Entry Biologic Revenue by Country (2017-2022) & (US$ Million)
Table 42. Europe Bio Similars & Subsequent Entry Biologic Revenue by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Bio Similars & Subsequent Entry Biologic Revenue by Company (2020-2022) & (US$ Million)
Table 44. Asia Pacific Bio Similars & Subsequent Entry Biologic Revenue by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Bio Similars & Subsequent Entry Biologic Revenue by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Bio Similars & Subsequent Entry Biologic Revenue by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Bio Similars & Subsequent Entry Biologic Revenue by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Bio Similars & Subsequent Entry Biologic Revenue by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Bio Similars & Subsequent Entry Biologic Revenue by Region (2023-2028) & (US$ Million)
Table 50. Latin America Bio Similars & Subsequent Entry Biologic Revenue by Company (2020-2022) & (US$ Million)
Table 51. Latin America Bio Similars & Subsequent Entry Biologic Revenue by Type (2017-2022) & (US$ Million)
Table 52. Latin America Bio Similars & Subsequent Entry Biologic Revenue by Type (2023-2028) & (US$ Million)
Table 53. Latin America Bio Similars & Subsequent Entry Biologic Revenue by Application (2017-2022) & (US$ Million)
Table 54. Latin America Bio Similars & Subsequent Entry Biologic Revenue by Application (2023-2028) & (US$ Million)
Table 55. Latin America Bio Similars & Subsequent Entry Biologic Revenue by Country (2017-2022) & (US$ Million)
Table 56. Latin America Bio Similars & Subsequent Entry Biologic Revenue by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Bio Similars & Subsequent Entry Biologic Revenue by Company (2020-2022) & (US$ Million)
Table 58. Middle East and Africa Bio Similars & Subsequent Entry Biologic Revenue by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Bio Similars & Subsequent Entry Biologic Revenue by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Bio Similars & Subsequent Entry Biologic Revenue by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Bio Similars & Subsequent Entry Biologic Revenue by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Bio Similars & Subsequent Entry Biologic Revenue by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Bio Similars & Subsequent Entry Biologic Revenue by Country (2023-2028) & (US$ Million)
Table 64. Sun Pharma Company Details
Table 65. Sun Pharma Business Overview
Table 66. Sun Pharma Bio Similars & Subsequent Entry Biologic Product and Services
Table 67. Sun Pharma Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
Table 68. Sun Pharma Bio Similars & Subsequent Entry Biologic SWOT Analysis
Table 69. Sun Pharma Recent Developments
Table 70. Synthon Pharmaceuticals Company Details
Table 71. Synthon Pharmaceuticals Business Overview
Table 72. Synthon Pharmaceuticals Bio Similars & Subsequent Entry Biologic Product and Services
Table 73. Synthon Pharmaceuticals Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
Table 74. Synthon Pharmaceuticals Bio Similars & Subsequent Entry Biologic SWOT Analysis
Table 75. Synthon Pharmaceuticals Recent Developments
Table 76. Teva Pharmaceutical Industries Company Details
Table 77. Teva Pharmaceutical Industries Business Overview
Table 78. Teva Pharmaceutical Industries Bio Similars & Subsequent Entry Biologic Product and Services
Table 79. Teva Pharmaceutical Industries Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
Table 80. Teva Pharmaceutical Industries Bio Similars & Subsequent Entry Biologic SWOT Analysis
Table 81. Teva Pharmaceutical Industries Recent Developments
Table 82. LG Life Sciences Company Details
Table 83. LG Life Sciences Business Overview
Table 84. LG Life Sciences Bio Similars & Subsequent Entry Biologic Product and Services
Table 85. LG Life Sciences Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
Table 86. LG Life Sciences Bio Similars & Subsequent Entry Biologic SWOT Analysis
Table 87. LG Life Sciences Recent Developments
Table 88. Celltrion Biocon Company Details
Table 89. Celltrion Biocon Business Overview
Table 90. Celltrion Biocon Bio Similars & Subsequent Entry Biologic Product and Services
Table 91. Celltrion Biocon Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
Table 92. Celltrion Biocon Bio Similars & Subsequent Entry Biologic SWOT Analysis
Table 93. Celltrion Biocon Recent Developments
Table 94. Hospira Company Details
Table 95. Hospira Business Overview
Table 96. Hospira Bio Similars & Subsequent Entry Biologic Product and Services
Table 97. Hospira Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
Table 98. Hospira Bio Similars & Subsequent Entry Biologic SWOT Analysis
Table 99. Hospira Recent Developments
Table 100. Merck Company Details
Table 101. Merck Business Overview
Table 102. Merck Bio Similars & Subsequent Entry Biologic Product and Services
Table 103. Merck Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
Table 104. Merck Bio Similars & Subsequent Entry Biologic SWOT Analysis
Table 105. Merck Recent Developments
Table 106. Biogen idec Company Details
Table 107. Biogen idec Business Overview
Table 108. Biogen idec Bio Similars & Subsequent Entry Biologic Product and Services
Table 109. Biogen idec Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
Table 110. Biogen idec Bio Similars & Subsequent Entry Biologic SWOT Analysis
Table 111. Biogen idec Recent Developments
Table 112. Genentech (Roche) Company Details
Table 113. Genentech (Roche) Business Overview
Table 114. Genentech (Roche) Bio Similars & Subsequent Entry Biologic Product and Services
Table 115. Genentech (Roche) Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
Table 116. Genentech (Roche) Bio Similars & Subsequent Entry Biologic SWOT Analysis
Table 117. Genentech (Roche) Recent Developments
Table 118. Pfizer Company Details
Table 119. Pfizer Business Overview
Table 120. Pfizer Bio Similars & Subsequent Entry Biologic Product and Services
Table 121. Pfizer Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
Table 122. Pfizer Bio Similars & Subsequent Entry Biologic SWOT Analysis
Table 123. Pfizer Recent Developments
Table 124. Celltrion Company Details
Table 125. Celltrion Business Overview
Table 126. Celltrion Bio Similars & Subsequent Entry Biologic Product and Services
Table 127. Celltrion Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
Table 128. Celltrion Recent Developments
Table 129. Biocon Company Details
Table 130. Biocon Business Overview
Table 131. Biocon Bio Similars & Subsequent Entry Biologic Product and Services
Table 132. Biocon Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
Table 133. Biocon Recent Developments
Table 134. Amgen Company Details
Table 135. Amgen Business Overview
Table 136. Amgen Bio Similars & Subsequent Entry Biologic Product and Services
Table 137. Amgen Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
Table 138. Amgen Recent Developments
Table 139. Samsung Biologics Company Details
Table 140. Samsung Biologics Business Overview
Table 141. Samsung Biologics Bio Similars & Subsequent Entry Biologic Product and Services
Table 142. Samsung Biologics Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
Table 143. Samsung Biologics Recent Developments
Table 144. Mylan Company Details
Table 145. Mylan Business Overview
Table 146. Mylan Bio Similars & Subsequent Entry Biologic Product and Services
Table 147. Mylan Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
Table 148. Mylan Recent Developments
Table 149. Dr. Reddy's Laboratories Company Details
Table 150. Dr. Reddy's Laboratories Business Overview
Table 151. Dr. Reddy's Laboratories Bio Similars & Subsequent Entry Biologic Product and Services
Table 152. Dr. Reddy's Laboratories Bio Similars & Subsequent Entry Biologic Revenue in Bio Similars & Subsequent Entry Biologic Business (2017-2022) & (US$ Million)
Table 153. Dr. Reddy's Laboratories Recent Developments
Table 154. Stada Arzneimittel AG Company Details
Table 155. Stada Arzneimittel AG Business Overview
Table 156. Stada Arzneimittel AG Bio Similars & Subsequent Entry Biologic Product and Services
Table 157. Stada Arzneimittel AG Bio Similars & Subsequent Entry Biologic Revenue in

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs